Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MD.0000000000021774 http://scihub22266oqcxt.onion/10.1097/MD.0000000000021774 32871898!7458227!32871898     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Medicine+(Baltimore) 2020 ; 99 (35): e21774 Nephropedia Template TP {{tp|p=32871898|t=2020. Traditional Chinese medicine for corona virus disease 2019: A protocol for systematic review |pdf=|usr=}}{{32871898}} gab.com Text Traditional Chinese medicine for corona virus disease 2019: A protocol for systematic review JO: Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=32871898 #FOAvip BACKGROUND: Assessing the effectiveness and safety of Traditional Chinese medicine for treating patients with corona virus disease 2019 (COVID-19) is the main purpose of this systematic review protocol. METHODS: The following electronic databases will be searched from inception to April 2020: Cochrane Central Register of Controlled Trials, PubMed, Web of Science, EMBASE, China National Knowledge Infrastructure, Traditional Chinese Medicine, Chinese Biomedical Literature Database, Wan-Fang Database, and Chinese Scientific Journal Database. All published randomized controlled trials in English or Chinese related to Traditional Chinese medicine for COVID-19 will be included. Primary outcomes are time of disappearance of main symptoms and serum cytokine levels. Secondary outcomes is Accompanying symptoms disappear rate, negative COVID-19 results rate on 2 consecutive occasions CT image improvement, average hospitalization time, occurrence rate of common type to severe form, clinical cure rate, and mortality. Two reviewers will conduct the study selection, data extraction, and assessment independently. The assessment of risk of bias and data synthesis will be conducted with Review Manager Software V.5.2. RESULTS: The results will provide a high-quality synthesis of current evidence for researchers in this subject area. CONCLUSION: The conclusion of our study will provide evidence to judge whether traditional Chinese medicine is an effective intervention for COVID-19 patients. PROSPERO REGISTRATION NUMBER: CRD42020181006. Twit Text FOAVip Traditional Chinese medicine for corona virus disease 2019: A protocol for systematic review ????Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=32871898 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32871898 #FOAvip English Wikipedia <ref>{{Cite pmid|32871898}}</ref> Traditional Chinese medicine for corona virus disease 2019: A protocol for systematic review #MMPMID32871898 Huang J; Wu L; Ren X; Wu X; Chen Y; Ran G; Huang A; Huang L; Zhong D Medicine (Baltimore) 2020[Aug]; 99 (35): e21774 PMID32871898show ga BACKGROUND: Assessing the effectiveness and safety of Traditional Chinese medicine for treating patients with corona virus disease 2019 (COVID-19) is the main purpose of this systematic review protocol. METHODS: The following electronic databases will be searched from inception to April 2020: Cochrane Central Register of Controlled Trials, PubMed, Web of Science, EMBASE, China National Knowledge Infrastructure, Traditional Chinese Medicine, Chinese Biomedical Literature Database, Wan-Fang Database, and Chinese Scientific Journal Database. All published randomized controlled trials in English or Chinese related to Traditional Chinese medicine for COVID-19 will be included. Primary outcomes are time of disappearance of main symptoms and serum cytokine levels. Secondary outcomes is Accompanying symptoms disappear rate, negative COVID-19 results rate on 2 consecutive occasions CT image improvement, average hospitalization time, occurrence rate of common type to severe form, clinical cure rate, and mortality. Two reviewers will conduct the study selection, data extraction, and assessment independently. The assessment of risk of bias and data synthesis will be conducted with Review Manager Software V.5.2. RESULTS: The results will provide a high-quality synthesis of current evidence for researchers in this subject area. CONCLUSION: The conclusion of our study will provide evidence to judge whether traditional Chinese medicine is an effective intervention for COVID-19 patients. PROSPERO REGISTRATION NUMBER: CRD42020181006. |*Coronavirus Infections/epidemiology/therapy[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/epidemiology/therapy[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Humans[MESH] |Medicine, Chinese Traditional/*methods[MESH] |Research Design[MESH] |SARS-CoV-2[MESH] |Systematic Reviews as Topic[MESH]Traditional Chinese medicine for corona virus disease 2019: A protocol(epmc).pdf DeepDyve Pubget Overpricing